Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

Central Silk Board Life Science Project Assistant Jobs | Applications Invited

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies
  • BiotechToday
  • India
  • World

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

bioxone October 11, 2020October 10, 2020

-Richismita Hazra, Amity University Kolkata

Antibodies serve as analytical barriers to viruses or viral infections. They play a dual role in communicating the existence of invading pathogens in infected cells, also, in interfering with the processes that are essential to the viral lifecycle. The antibodies activate phagocytes which is a potential mechanism of eradiating viruses. A virus-bound antibody binds to receptors, on the surface of phagocytic cells and undergoes phagocytosis thereby engulfing and hence destroying the virus.

So, antibodies against viral pathogens have proved remedial processes for the control of infections and researches from the past have entrenched that their antiviral potency is based on the combined effectiveness or functioning of Fab and Fc domains.

The Fragment Antigen-Binding fragment (Fab) is the region of an antibody to which the antigens bind.

The Fragment Crystallizable (Fc) region plays a role in modulating immune cell activity. This region binds to specific proteins and establishes the fact that each antibody generates an appropriate immune response for a particular antigen. By binding to Fc receptors (FcγRs) and other immune molecules, the Fc domain mediates various physiological effects like cell lysis and triggers the clearance of virus and destruction of infected cells. This research reports that when Fc of the anti-influenza IgG monoclonal antibodies (mAbs) is engineered for selective binding to the activating FcγR, FcγRIIa, it results in an improvement in the prevention or treatment of lethal viral respiratory infection with upgraded dendritic cell maturation and induction of protective CD8+ T-cell responses. This research highlights that IgG antibodies have the capability of promoting protective adaptive immunity towards viral infections on selective activation of dendritic cell-T cell pathway. This has a remarkable influence on the development of antibody therapeutics with upgraded antiviral effectiveness against viral respiratory pathogens.

Source: DOI https://doi.org/10.1038/s41586-020-2838-z

Also read: World Sight Day 2020: I for an Eye

For more articles, visit bioxone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibodies antibody and viral infection antibody domain antigen and antibody antigens antiviral antibody cell immune cell activity immunology pathogen infection respiratory pathogens viral antibody enhancement viral infections

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Central Silk Board Life Science Project Assistant Jobs | Applications Invited

bioxone October 11, 2020

-Shristi Sharma, Team bioXone Government Life Science Project Assistant Job at CMER&TI. Central Muga Eri Research & Training Institute Life Science Project Assistant Job Opening. BSc Life Science Project Assistant Job. Interested and eligible applicants can check out all of the details on the same below: Applications are welcomed from the eligible applicants for engagement […]

Related Post

  • BiotechToday
  • World

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

bioxone February 8, 2021February 7, 2021

Husna, Amity University Kolkata African trypanosomiasis, also known as sleeping sickness is a disease fatal to both humans and animals. It is transmitted to humans and animals by the tsetse fly.  A vaccine for protection from this disease hasn’t been discovered making its transmission control rely on eliminating the tsetse fly population. Neurotoxic insecticides and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

Fungi to save astronauts from ionizing space radiations

bioxone September 7, 2020September 7, 2020

-Anuska Sen, Amity University Kolkata During space missions, when astronauts cross the magnetosphere layer of the Earth, they are exposed to the harmful ionizing space radiations. Although the stainless steel shields are potent enough to save them but these are in no way economical and handy. Researcher G.K. Shunk and the group have come up […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

IS OBESITY AND HYPERURICEMIA RELATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE?

bioxone February 13, 2021February 12, 2021

Shrestha Dutta, Amity University Kolkata Non-alcoholic fatty liver disease (NAFLD) is the most quickly spreading chronic liver sickness. It is closely identified with metabolic disorder and its related conditions, including obesity, type 2 diabetes, dyslipidemia, hypertension, and hyperuricemia. Past studies have uncovered a connection between hyperuricemia and the seriousness of liver damage in NAFLD. A […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy